Prestigious grant HORIZON EUROPE - “BEATsep” will tackle long-term consequences of sepsis.
The research consortium BEATsep, established by the Cellular and Molecular Immunoregulation (CMI) research team at the International Clinical Research Centre (ICRC), has been awarded a 6.9 million euro HORIZON EUROPE grant. The project entitled “Biomarkers established to stratify sepsis long-term adverse effects to improve patients’ health and quality of life (BEATsep) aims to define markers of poor recovery of patients after sepsis and septic shock. This will be achieved through the discovery of novel mechanisms and their markers predicting the decline of health-related quality of life after sepsis. Sepsis and septic shock, affecting up to 50 million people worldwide with mortality reaching 20%, leaves large cohorts of vulnerable patients suffering from long-term complications that affect their quality of life.
